Literature DB >> 33716947

Endothelial Shear Stress and Platelet FcγRIIa Expression in Intracranial Atherosclerotic Disease.

David S Liebeskind1, Jason D Hinman1, Naoki Kaneko1, Hiroaki Kitajima1, Tristan Honda1, Adam H De Havenon2, Edward Feldmann3, Raul G Nogueira4, Shyam Prabhakaran5, Jose G Romano6, Peter W Callas7, David J Schneider8.   

Abstract

Intracranial atherosclerotic disease (ICAD) has been characterized by the degree of arterial stenosis and downstream hypoperfusion, yet microscopic derangements of endothelial shear stress at the luminal wall may be key determinants of plaque growth, vascular remodeling and thrombosis that culminate in recurrent stroke. Platelet interactions have similarly been a principal focus of treatment, however, the mechanistic basis of anti-platelet strategies is largely extrapolated rather than directly investigated in ICAD. Platelet FcγRIIa expression has been identified as a potent risk factor in cardiovascular disease, as elevated expression markedly increases the risk of recurrent events. Differential activation of the platelet FcγRIIa receptor may also explain the variable response of individual patients to anti-platelet medications. We review existing data on endothelial shear stress and potential interactions with the platelet FcγRIIa receptor that may alter the evolving impact of ICAD, based on local pathophysiology at the site of arterial stenosis. Current methods for quantification of endothelial shear stress and platelet activation are described, including tools that may be readily adapted to the clinical realm for further understanding of ICAD.
Copyright © 2021 Liebeskind, Hinman, Kaneko, Kitajima, Honda, De Havenon, Feldmann, Nogueira, Prabhakaran, Romano, Callas and Schneider.

Entities:  

Keywords:  FcγRIIa receptor; intracranial atherosclerosis; platelet activation and reactivity; shear stress; stroke

Year:  2021        PMID: 33716947      PMCID: PMC7947292          DOI: 10.3389/fneur.2021.646309

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  57 in total

1.  Collaterals 2016: Translating the collaterome around the globe.

Authors:  David S Liebeskind; Graham W Woolf; Ashfaq Shuaib
Journal:  Int J Stroke       Date:  2017-03-27       Impact factor: 5.266

2.  STAIR X: Emerging Considerations in Developing and Evaluating New Stroke Therapies.

Authors:  David S Liebeskind; Colin P Derdeyn; Lawrence R Wechsler
Journal:  Stroke       Date:  2018-09       Impact factor: 7.914

3.  Editorial commentary: Beyond the guidelines to expertise in precision stroke medicine.

Authors:  David S Liebeskind
Journal:  Trends Cardiovasc Med       Date:  2016-08-08       Impact factor: 6.677

Review 4.  Platelet-reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta-analysis.

Authors:  P P Wisman; M Roest; F W Asselbergs; P G de Groot; F L Moll; Y van der Graaf; G J de Borst
Journal:  J Thromb Haemost       Date:  2014-05       Impact factor: 5.824

5.  Hemodynamics and stroke risk in intracranial atherosclerotic disease.

Authors:  Xinyi Leng; Linfang Lan; Hing Lung Ip; Jill Abrigo; Fabien Scalzo; Haipeng Liu; Xueyan Feng; Ka Lung Chan; Florence S Y Fan; Sze Ho Ma; Hui Fang; Yuming Xu; Jingwei Li; Bing Zhang; Yun Xu; Yannie O Y Soo; Vincent C T Mok; Simon C H Yu; David S Liebeskind; Ka Sing Wong; Thomas W Leung
Journal:  Ann Neurol       Date:  2019-04-03       Impact factor: 10.422

6.  Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in platelet function.

Authors:  Andrew L Frelinger; Deepak L Bhatt; Ronald D Lee; Darcy J Mulford; Jingtao Wu; Sai Nudurupati; Anu Nigam; Michael Lampa; Julie K Brooks; Marc R Barnard; Alan D Michelson
Journal:  J Am Coll Cardiol       Date:  2013-01-16       Impact factor: 24.094

7.  Platelet FcgammaRIIA His131Arg polymorphism and platelet function: antibodies to platelet-bound fibrinogen induce platelet activation.

Authors:  J Chen; J-F Dong; C Sun; A Bergeron; L McBride; M Pillai; M R Barnard; J Salmon; A D Michelson; P F Bray
Journal:  J Thromb Haemost       Date:  2003-02       Impact factor: 5.824

8.  Temporal variability in the antiplatelet effects of clopidogrel and aspirin after elective drug-eluting stent implantation. An ADAPT-DES substudy.

Authors:  Thomas G Nührenberg; Christian Stratz; Stefan Leggewie; Willibald Hochholzer; Christian M Valina; Michael Gick; Ajay J Kirtane; Gregg W Stone; Franz-Josef Neumann; Dietmar Trenk
Journal:  Thromb Haemost       Date:  2015-08-13       Impact factor: 5.249

9.  Shear-induced platelet aggregation in normal subjects and stroke patients.

Authors:  K Konstantopoulos; J C Grotta; C Sills; K K Wu; J D Hellums
Journal:  Thromb Haemost       Date:  1995-11       Impact factor: 5.249

10.  Interaction between the Stress Phase Angle (SPA) and the Oscillatory Shear Index (OSI) Affects Endothelial Cell Gene Expression.

Authors:  Ronny Amaya; Limary M Cancel; John M Tarbell
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.